Calorie Restriction for Health & Longevity - Quick Reference Sheet

Calorie Restriction for Health & Longevity

Created on 06/23/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Eating meaningfully less while staying well-nourished reliably lowers weight, blood fats, blood sugar, blood pressure, and inflammation, and may modestly slow some aging markers — clearest for those carrying excess fat. Trade-offs include muscle and bone loss, hunger, and lower energy use. Whether it lengthens human life remains unknown, and almost no one sustains it. (Full Review)

Protocol

Restriction Depth
10–25% below maintenance
Sustained reduction prioritizing nutrient density; mirrors the CALERIE design (targeted 25%, achieved ~12%).
Pattern
Continuous or intermittent
Steady daily deficit versus alternate-day fasting or time-restricted eating; neither is established as superior for longevity.
Timing
Front-load calories earlier
Total intake matters more than distribution, but eating earlier favors better glucose handling; very late eating is discouraged.
Time to effect
Weight & Cardiometabolic
Within weeks
Weight and cardiometabolic markers begin improving.
Lipids, Glucose, BP
1–3 months
Meaningful changes in lipids, glucose, and blood pressure typically seen.
Biological-Aging Markers
~2 years
Measured over the 2-year CALERIE timeframe.

Benefits

Contraindications
  • Pregnancy or breastfeeding
  • Children and adolescents
  • Current or past eating disorder
  • Underweight (BMI < 18.5 kg/m²)
  • Osteoporosis (T-score ≤ −2.5) or significant frailty
  • Type 1 diabetes
Key Interactions
  • Glucose-lowering drugs (insulin, sulfonylureas)
  • Blood-pressure drugs (lisinopril, amlodipine)
  • Warfarin
  • NSAIDs (ibuprofen)
  • OTC sleep aids and stimulants
  • Glucose-lowering supplements (berberine, chromium)
  • Blood-pressure-lowering supplements (potassium, magnesium, fish oil)

Risk & Side Effects

  • High: Loss of lean muscle mass; bone mineral density loss
  • Medium: Persistent hunger and increased appetite signaling; reduced resting metabolic rate
  • Low: Cold intolerance, fatigue, and reduced libido; menstrual irregularity and reproductive suppression
  • Speculative: Impaired immune function or wound healing; excess leanness and frailty in older adults

Monitoring

Marker Target Why
Fasting glucose 75–85 mg/dL Tracks glycemic improvement
Fasting insulin 2–5 µIU/mL Sensitive marker of insulin sensitivity
LDL cholesterol < 100 mg/dL (lower if high-risk) Cardiovascular risk; falls with calorie restriction
Triglycerides < 80 mg/dL Responsive to energy restriction
hsCRP < 1.0 mg/L Tracks chronic inflammation
Bone mineral density (DEXA) T-score above −1.0 Detects CR-driven bone loss
Appendicular lean mass (DEXA) Maintained from baseline Detects excess muscle loss
Vitamin D (25-OH) 30–50 ng/mL Supports bone protection
TSH 0.5–2.5 µIU/mL Detects restriction-driven thyroid slowing
Free T3 Mid-to-upper reference Sensitive to metabolic adaptation

Cadence: Lipids, glucose, and weight at ~1 and 3 months, then every 3–6 months; body composition and bone density by DEXA at baseline, then every 12–24 months.

Qualitative Assessment

  • Energy levels and persistent fatigue
  • Hunger intensity and food preoccupation
  • Sleep quality and night-time waking
  • Cold intolerance
  • Mood, irritability, and motivation
  • Libido and, in women, menstrual regularity
  • Physical strength and gym performance